Company Overview Visit questdiagnostics.com website
Quest Diagnostics is a Fortune 500 company that provides clinical laboratory services. The company is based in the United States but has international locations.
Founded in 1967, Quest Diagnostics has an expansive history that includes being publicly traded since 1991. The headquarters are located in New Jersey and are run by David M Rubenstein who is Chairman of the Board, Steve Rusckowski who serves as President, and Jeffrey A Smith who works as CEO. Since its founding over 50 years ago, Quest Diagnostics has grown to include more than 240 locations around the world with more expected to come in the future. The research arm of Quest Diagnostic is also significant contributing to life-saving technologies for early diagnosis and treatment of many of society's most complicated and serious illnesses.
Today, Quest Diagnostics is a leading national laboratory, providing clinical testing and information to more than 11 million patients annually in the United States. There are also international locations in Australia, Brazil, Canada and China. The company works with over 1,000 hospitals and reference laboratories representing 5% of the nation's hospital systems' revenues.
Quest Diagnostics offers a variety of services ranging from routine blood drawn at home to complex disease management solutions delivered by teams of physicians and nurses working together for an improved patient outcome. Additionally, the company helps over 475 biopharmaceutical companies manage patient trials which have contributed to life-saving therapies including Herceptin for breast cancer treatment as well as Adderall and Concerta for attention deficit disorders.